Evidence map›Paper›PMID 36823998›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2023

Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke.

Alessia Valente, Jacopo Mariani, Serena Seminara, Mauro Tettamanti, Giuseppe Pignataro, Carlo Perego, Luigi Sironi, Felicita Pedata, Diana Amantea, Marco Bacigaluppi and 22 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Alessia ValenteIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.ORCID 0000-0002-6917-9278
Jacopo MarianiSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Serena SeminaraIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Mauro TettamantiIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Giuseppe PignataroDepartment of Neuroscience, Reproductive Sciences and Dentistry, Federico II University of Naples, Napoli, Italy.ORCID 0000-0002-7290-4397
Carlo PeregoIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Luigi SironiDepartment of Pharmaceutical Sciences, University of Milan, Milano, Italy.
Felicita PedataDepartment of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Division of Pharmacology and Toxicology, University of Florence, Firenze, Toscana, Italy.
Diana AmanteaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (Cosenza), Italy.ORCID 0000-0002-7513-3495
Marco BacigaluppiNeuroimmunology Unit, San Raffaele Hospital and Università Vita-Salute San Raffaele, Milano, Lombardia, Italy.ORCID 0000-0002-0213-2328
Antonio VinciguerraDepartment of Biomedical Science and Public Health, Marche Polytechnic University, Ancona, Italy.
Susanna DiamantiSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Martina ViganòSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Francesco SantangeloSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0001-7724-6875
Chiara Paola ZoiaSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Virginia Rodriguez-MenendezSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Laura CastiglioniDepartment of Pharmaceutical Sciences, University of Milan, Milano, Italy.
Joanna RzemieniecDepartment of Pharmaceutical Sciences, University of Milan, Milano, Italy.
Ilaria DettoriDepartment of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Division of Pharmacology and Toxicology, University of Florence, Firenze, Toscana, Italy.
Irene BulliDepartment of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Division of Pharmacology and Toxicology, University of Florence, Firenze, Toscana, Italy.
Elisabetta CoppiDepartment of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Division of Pharmacology and Toxicology, University of Florence, Firenze, Toscana, Italy.
Chiara Di SantoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (Cosenza), Italy.
Ornella CuomoDepartment of Neuroscience, Reproductive Sciences and Dentistry, Federico II University of Naples, Napoli, Italy.
Giorgia Serena GullottaNeuroimmunology Unit, San Raffaele Hospital and Università Vita-Salute San Raffaele, Milano, Lombardia, Italy.
Erica ButtiNeuroimmunology Unit, San Raffaele Hospital and Università Vita-Salute San Raffaele, Milano, Lombardia, Italy.
Giacinto BagettaDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (Cosenza), Italy.
Gianvito MartinoNeuroimmunology Unit, San Raffaele Hospital and Università Vita-Salute San Raffaele, Milano, Lombardia, Italy.
Maria-Grazia De SimoniIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Carlo FerrareseSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Stefano FumagalliIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Simone BerettaSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
TRICS study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicentre preclinical randomized controlled trials (pRCTs) are a valuable tool to improve experimental stroke research, but are challenging and therefore underused. A common challenge regards the standardization of procedures across centres. We here present the harmonization phase for the quantification of sensorimotor deficits by composite neuroscore, which was the primary outcome of two multicentre pRCTs assessing remote ischemic conditioning in rodent models of ischemic stroke. Ischemic stroke was induced by middle cerebral artery occlusion for 30, 45 or 60 min in mice and 50, 75 or 100 min in rats, allowing sufficient variability. Eleven animals per species were video recorded during neurobehavioural tasks and evaluated with neuroscore by eight independent raters, remotely and blindly. We aimed at reaching an intraclass correlation coefficient (ICC) ≥0.60 as satisfactory interrater agreement. After a first remote training we obtained ICC = 0.50 for mice and ICC = 0.49 for rats. Errors were identified in animal handling and test execution. After a second remote training, we reached the target interrater agreement for mice (ICC = 0.64) and rats (ICC = 0.69). In conclusion, a multi-step, online harmonization phase proved to be feasible, easy to implement and highly effective to align each centre's behavioral evaluations before project's interventional phase.

Indexed as

Brain IschemiaIschemic StrokeStrokeAnimalsInfarction, Middle Cerebral ArteryMiceRandomized Controlled Trials as TopicRatsinterrater agreementIschemic strokeneurobehaviorpreclinical multicentre trialquality check

Identifiers

PMID36823998
PMCPMC10291454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.